US Markets
Home›US Markets›Equities›Moderna shares surge after skin cancer therapy breakth…
Moderna shares surge after skin cancer therapy breakthrough
The stock move comes as the market weighs new healthcare momentum alongside a broader inflation rebound driven by higher gas bills.
Moderna shares nearly doubled after the company reported a skin cancer therapy breakthrough, a major development for investors focused on pipeline progress.
In the broader market backdrop, Guardian Business highlighted an inflation rebound driven by the biggest jump in gas bills since October 2022, a factor that can influence rate expectations and equity sentiment.
At the same time, the business live coverage pointed to weakness in Asian shares after a Wall Street chip sell-off, underscoring how sector and macro drivers are moving markets in tandem.
Guardian Business also noted separate developments in AI, including that OpenAI has slowed the pace of AI development as it overhauled its research and training systems, reflecting a mix of catalysts influencing investor attention.